tj-14

Small moleculeexperimental

Clinical trial activity

6 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2006 (NCT00294125)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • 7-d-glucuronic acid-5,6-dihydroxyflavone
  • 7-d-glucuronic acid-5,6-dihydroxy-flavone
  • baicalin
  • baicalin
  • baicalin
  • baicalin
  • baicalin
  • flavocoxid
  • flavocoxid
  • flavocoxid
  • limbrel
  • tj-14

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01335295Phase 1Mar 1, 2011University of Messina
NCT00790985N/AJan 1, 2008AmeRuss Clinical Trials LLC, USA, Primus Pharmaceuticals
NCT00435292N/AApr 1, 2006Primus Pharmaceuticals
NCT00303017N/AMar 1, 2006MIMA Century Research Associates, Primus Pharmaceuticals, Sun Valley Arthritis Ltd, Glendale
NCT00928837N/AMar 1, 2006Altoona Center for Clinical Research, Arthritis and Osteoporosis Center of Maryland, MIMA Century Research Associates, Primus Pharmaceuticals, Sun Valley Arthritis Ltd, Glendale
NCT00294125Phase 1Feb 1, 2006National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Primus Pharmaceuticals, University of Alabama, Birmingham
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Primus PharmaceuticalsFor profit5422006
MIMA Century Research AssociatesFor profit2012006
Sun Valley Arthritis Ltd, GlendaleAcademic/Hospital2012006
Altoona Center for Clinical ResearchFor profit1012006
AmeRuss Clinical Trials LLC, USAFor profit1012008
Arthritis and Osteoporosis Center of MarylandAcademic/Hospital1012006
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Government1012006
University of Alabama, BirminghamAcademic/Hospital1112006
University of MessinaAcademic/Hospital1112011
9 organizations
Page 1 / 1